CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Joel Gelernter

OPENALEX: A5044047568↗ORCID: 0000-0002-4067-1859↗

Affiliations

Organizations

Boston Public Schoolsauthorship · US Boston Universityauthorship · US Connecticut Health Foundationauthorship · US Department of Veterans Affairsauthorship · AU Hartford Hospitalauthorship · US Mental Illness Research, Education and Clinical Centersauthorship · US Program Support Centerauthorship · US The University of Texas at Austinauthorship · US University of New Havenauthorship · US University of Pennsylvaniaauthorship · US VA Connecticut Healthcare Systemauthorship · US VA Healthcare-VISN 4authorship · US Yale Universityauthorship · US

Public evidence

10 connected articles

Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders2022 · medRxiv The genetics of cannabis lifetime use.2026 · Europe PMC Differences and similarities between the genetic architecture of lifetime substance use across different substances.2025 · Europe PMC Association between cannabis use and brain structure and function: an observational and Mendelian randomisation study.2024 · Europe PMC Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking.2024 · Europe PMC Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications2023 · PubMed Central Open Access Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci2022 · PubMed Central Open Access Genome-wide association study of stimulant dependence.2021 · PubMed Central Open Access A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans.2019 · PubMed Central Open Access Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium.2016 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Joel Gelernter - Medical Cannabis Research Engine